ArticleInternational journal of clinical oncology2024

Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study.

Yoshiyuki Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.